Benefit-risk management in the age of personalized healthcare

Personalized Medicine
Michael Forstner

Abstract

The ongoing developments in personalized healthcare are opening new possibilities for the optimization of the benefit-risk profiles of drugs based on the stratification of patients. Beyond this straightforward application of pharmacogenomics to the optimization of benefit-risk profiles, other approaches, such as metabolomics and systems pharmacology, may contribute to an improved use of medicines in a personalized healthcare setting. These will, however, require fundamental adaptations or new developments in various areas and by all stakeholders, including the pharmaceutical and diagnostics industries, regulators, physicians and patients. Ultimately, personalized healthcare should enable patients to take personal decisions on treatment options based on their preferred benefit-risk profiles of therapeutics.

References

May 21, 2005·Nature Reviews. Drug Discovery·Mark Ratner
Jan 18, 2006·The Pharmacogenomics Journal·R Simon, S-J Wang
May 9, 2007·Health Affairs·Louis P GarrisonBrian W Bresnahan
Sep 23, 2008·American Journal of Therapeutics·Paul E StangKathleen Gondek
Oct 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Estelle Marrer, Frank Dieterle
Nov 26, 2008·The Pediatric Infectious Disease Journal·Douglas M Fleming, Alex J Elliot
Mar 31, 2009·Drug News & Perspectives·Jeffrey S Ross
Jun 10, 2009·Nature Reviews. Genetics·Wolf H RogowskiMuin J Khoury
Jan 13, 2010·Nature Reviews. Genetics·Alan E GuttmacherKári Stefánsson
Jan 21, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Rena ContiScott D Grosse
Sep 2, 2010·Experimental and Molecular Pathology·Leonardo M R Ferreira
Oct 5, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Garabed Eknoyan
Dec 24, 2010·Clinical Pharmacology and Therapeutics·B S LevitanF Mussen
Feb 12, 2011·Medical Decision Making : an International Journal of the Society for Medical Decision Making·George Van HoutvenA Brett Hauber
Mar 19, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Rodger Charlton
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
May 19, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Torbjörn Callréus
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 23, 2011·Pharmacogenomics·Mary W RoedererUNKNOWN Pharmacogenetics for Every Nation Initiative
Oct 1, 2011·Nature Reviews. Drug Discovery·Robert A BeckmanCong Chen
Oct 13, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·N Sattar
Jan 13, 2012·Annual Review of Pharmacology and Toxicology·Shan Zhao, Ravi Iyengar
Jan 14, 2012·Neoplasia : an International Journal for Oncology Research·Elisabetta VerganiMonica Rodolfo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.